BrandMemo | manage and share brands you love  Pharmamedix su Facebook  Pharmamedix su Twitter
 Home | News | About us | Comitato scientifico | Iscriviti | Utenti | Etica | Contenuti | Guida | Faq | Stage | Contatti
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Levofloxacina

Levoxacin, Tavanic e altri

Bibliografia - Quali fonti bibliografiche per Levofloxacina?


         
  1. Agenzia Italiana del Farmaco – AIFA, Nota informativa – Antibiotici chinolonici e fluorochinolinici per uso sistemico e inalatorio. Rischio di effetti indesiderati invalidanti, di lunga durata e potenzialmente permanenti e restrizioni d’uso, 2019, 8 aprile http://www.aifa.gov.it/content/nota-informativa-importante-su-medicinali-contenenti-fluorochinoloni-08042019

  2. Baden L.R. et al., JAMA, 2001, 286 (24), 3115.

  3. Bar-Oz B. et al., Eur. J. Obstet. Gynecol. Reprod. Biol., 2009, 143 (2), 75.

  4. Bauer L.A. et al., Antimicrob. Agents Chemother., 2005, 49 (4), 1649.

  5. Bellon A. et al., Eur. J. Clin. Pharmacol., 2009, 65 (10), 959.

  6. Bollettino d’Informazione sui Farmaci, 2009, 1, 24.

  7. Bril F. et al., Curr Drug Saf., 2010, 5 (1), 85.

  8. Brouwers J.R., Drug Saf., 1992, 7 (4), 268.

  9. Cambau E., Gutmann L., Drugs, 1993, 45 Suppl. 3, 15.

  10. Canut A. et al., J. Antimicrob. Chemother., 2007, 60 (3), 605.

  11. Cheng H. et al., Zhonghua Yi Xue Za Zhi, 2010, 90 (2), 79.

  12. Chien S.C. et al., J. Clin. Pharm. Ther., 2002, 27 (1), 7.

  13. Coban A.Y. et al., Chemotherapy, 2004, 50 (1), 22.

  14. Corrao G. et al., Drug Saf., 2006, 29, 889.

  15. De Abate C.A. et al., Respir. Care, 1997, 42, 206.

  16. Deng J.Y., Tovar J.M., Ann. Pharmacother., 2006, 40 (9), 1692.

  17. Dupont H.L., Drugs, 2006, 66, 303.

  18. Durey A. et al., Yonsei Med. J., 2010, 51 (3), 454.

  19. Empey P.E. et al., Ann. Pharmacother., 2001, 35 (6), 687.

  20. European Medicines Agency – EMA, EMA/668915/2018, 2018, 5 ottobre https://www.ema.europa.eu/documents/press-release/fluoroquinolone-quinolone-antibiotics-prac-recommends-restrictions-use_en.pdf (accesso: ottobre 2018).

  21. European Medicines Agency – EMA, 2018a, EMA/795349/2018, 2018, 16 novembre.

  22. Faruquee C.F. et al., Pak. J. Pharm. Sci., 2010, 23 (2), 143.

  23. Federico S. et al., Clin. Pharmacokinet., 2006, 45 (2), 169.

  24. File T.M., Antimicrob. Agents Chemother., 1997, 41, 1965.

  25. Fish D.N., Chow A.T., Clin. Pharmacokinet., 1997, 32 (2), 101.

  26. Food and Drug Administration – FDA, FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes, 2018, 10 luglio https://www.fda.gov/Drugs/DrugSafety/ucm611032.htm (accesso: agosto 2018).

  27. Fu K.P. et al., Microbiology & Infect. Dis., 1992a, 15, 375.

  28. Fuhr U. et al., Antimicrob. Agents Chemother., 1992, 36 (5), 942.

  29. Gargallo Viola D. et al., Antimicrobial. Agents Chemother., 1991, 35 (3), 442.

  30. Giamarellou H. et al., Am. J. Med., 1989, 87 (5A), 49S.

  31. Habib M.P. et al., Infect. Dis. Clin. Pract., 1998, 7, 101.

  32. Hsiao S.H. et al., Ann. Pharmacother., 2005, 39 (1), 146.

  33. Informazioni sui farmaci, 1998, 5, 117.

  34. Informazioni sui farmaci, 2009, 4, 95.

  35. Iwamoto K. et al., Drugs, 1993, 45 Suppl. 3, 290.

  36. Jones C.B., Fugate S.E., Ann. Pharmacother., 2002, 36 (10), 1554.

  37. Kelesidis T. et al., J. Clin. Microbiol., 2010, consultabile on line all’indirizzo: http://www.ncbi.nlm.nih.gov/pubmed/20305011

  38. Kim J. et al., Drug Metab. Pharmacokinet., 2009, 24 (2), 167.

  39. Lardizabal D.V., Headache, 2009, 49 (2), 300.

  40. Larsen H. et al., Int. J. Antimicrob. Agents., 2001, 18 (3), 259.

  41. Lee L.J. et al., Antimicrob. Agents Chemother., 1997, 41 (10), 2196.

  42. Lewin C.S. et al., J. Pharmacy Pharmacol., 1991, 43, 492.

  43. Lewis R.J., Mohr J.F. 3rd., Drug Saf., 2008, 31 (4), 283.

  44. Liu H.H. et al., Drug Saf., 2010, 33 (5), 353.

  45. McGregor J.C. et al., Ther. Clin. Risk Manag., 2008, 4 (5), 843.

  46. Morrissey I. et al., J. Pharmacy Pharmacol., 1992, 44 Suppl., 1057.

  47. Murillo O. et al., Antimicrob. Agents Chemother., 2008, 52 (10), 3681.

  48. Muzi F. et al., Transplant Proc., 2007, 39, 1673.

  49. Nakamura H. et al., Ann. Pharmacother., 2001, 35 (6), 691.

  50. Nakashima M. et al., Jap. J. Clin. Pharmacol. Therap., 1992, 23, 515.

  51. Nichols R.L. et al., South Med. J., 1997, 90, 1193.

  52. Nicodemo A.C. et al., Int. J. Clin. Pract., 1998, 52, 69.

  53. Norrby S.R. et al., Scand. J. Infect. Dis., 1998, 30, 397.

  54. Oh Y.R. et al., Ann. Pharmacother., 2003, 37 (7-8), 1010.

  55. Paglia M. et al., Curr. Med. Res. Opin., 2010, consultabile on line all’indirizzo: http://www.ncbi.nlm.nih.gov/pubmed/20394471

  56. Pai M.P. et al., J. Cyst. Fibros., 2006, 5 (3), 153.

  57. Papastavros T. et al., C.M.A.J., 2002, 167 (2), 131.

  58. Patel P.D. et al., Tex. Heart Inst. J., 2010, 37 (2), 216.

  59. Petitjeans F. et al., Eur. J. Clin. Pharmacol., 2003, 59 (10), 779.

  60. Rao G.A. Et al., Ann. Farm. Med., 2014, 12 (2), 121

  61. Richard G.A. et al., Urology, 1998, 52, 51.

  62. Saraya A. et al., Eur. J. Pharmacol., 2004, 497 (1), 111.

  63. Shakeri-Nejad K., Stahlmann R., Expert. Opin. Pharmacother., 2006, 7 (6), 639.

  64. Shi R. et al., Mini Rev. Med. Chem., 2007, 7 (11), 1177.

  65. Simkó J. et al., Infection, 2008, 36 (3), 194.

  66. Slobodin G. et al., Neurol. Sci., 2009, 30 (2), 159.

  67. Stergiopoulou T. et al., J. Antimicrob. Chemother., 2009, 63 (2), 343.

  68. Sultana N. et al., Pak. J. Pharm. Sci., 2004, 17 (2), 67.

  69. Tanaka M. et al., J. Antimicrob. Ther., 1990, 26, 659.

  70. The Medical letter, 2002, 10, 43.

  71. The Medical letter, 2008, 18, 71.

  72. Tsang K.W. et al., Eur. Respir. J., 1999, 14 (5), 1206.

  73. Vadlamudi R.S. et al., South. Med. J., 2007, 100 (7), 720.

  74. Wallace A.W. et al., J. Clin. Pharmacol., 2003, 43 (5), 539.

  75. Watanabe T. et al., Arzneimittelforschung, 1992, 43 (3A), 374.

  76. West M. et al., Clin. Ther., 2003, 25 (2), 485.

  77. Wogelius P. et al., Int. J. Antimicrob. Agents., 2005, 26 (4), 323.

  78. Yokota T. et al., Chemother., 1992, 40 Suppl. 3, 27.